Wound closure and advanced wound care devices are the medical apparatus used for the closure of the wound by pulling the cut edges of the tissues together or by directly acting on the wounds for better healing. Devices such as sutures, strips, sealants and adhesives, clips, staples, energy based devices, haemostats and skin grafts are used to minimize the trauma and infection leading to a better and a scar-free healing. The wound closure and advanced wound care global market is segmented based on the products, applications, end-users and geography. Products are divided into primary and secondary wound closure products. Primary wound closure devices include surgical sutures, wound closure strips, staples, ligating clips, haemostat, adhesives and sealants. Surgical suture market is segmented into suture and automated suturing device. Suture market is further divided based on types, filaments, and material type. Sealants are divided into natural and synthetic sealant. Natural sealants are collagen, fibrin and albumin. Synthetic sealants are divided into cyanoacrylate, polymer and others. Haemostats are divided into flowable haemostats, fibrin sealants, mechanical haemostats and active haemostats.
Secondary wound closure devices include energy based devices, therapy based devices, moist wound therapy and biologics. Energy based devices are divided into laser devices, electrical stimulations, electromagnetic stimulations, ultra sound therapy, radio frequency therapy and ultra violet therapy. Therapy based devices are further segmented into hyperbaric oxygen therapy, negative pressure wound therapy and pressure relief devices. Biologics are divided into skin grafts and growth factor. Moist wound therapy is segmented into film, foam, hydrocolloids, hydrogels, alginate and collagen dressings.
By application, the wound closure and advanced wound care markets are divided into burns, ulcers, surgical wounds, trauma and laceration and radionecrosis. Ulcers are further divided into pressure ulcers, arterial ulcers, venous leg ulcers and diabetic foot ulcers. Surgical wound are divided into general surgery, cardio vascular surgery, neuro and spine surgery, ENT surgery, orthopaedic surgery, urology surgery, oncology surgery, obstetrics and gynaecology surgery and plastics, cosmetics and reconstruction surgery. Based on the end- users market is segmented into hospitals, community healthcare services and home healthcare.
Among the wound closure and advanced wound care products, the primary wound closure market dominated the products market by occupying a largest share. At the same time, secondary wound closure market is the fastest growing segment growing at high single digit CAGR from 2016 to 2023. In applications, the surgical wounds are the largest segment grand ulcers are the fastest growing segment with a high single digit CAGR 2016 to 2023. Among end- users, hospitals was the largest segment and also, the fastest growing segment growing at mid single digit from 2016 to 2023. Geography wise, North America is the largest market, followed by Europe and Asia. The APAC region is the fastest growing region growing at high single digit CAGR from 2016 to 2023 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the wound closure and advanced wound care market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, aging population and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The wound closure and advanced wound care market is expected to grow steadily at a mid single digit CAGR from 2016 to 2023 to reach $25,268.9 million by 2023. The factors driving the growth of this market are increase in aging population and prevalence of lifestyle diseases, increase in surgical procedural volume, increase in prevalence of chronic wounds and government initiatives are some of the factors driving the wound closure and advanced wound care market. Demand for biologics, emergence of technically advanced products and acquisition to open an array of opportunities for market to flourish are some of the opportunities for wound closure and advanced wound care market. However, lack of trained professional in handling the sophisticated advanced wound care techniques, expensive sealants and glues impeding effective penetration in low and middle income countries are some of the factors hampering the market growth. The threats for the wound closure and advanced wound care market include unfavourable reimbursement policies in developing nations and stringent regulatory bodies guiding the wound closure and advanced wound care manufacturers.
The wound closure and advanced wound care global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the wound closure and advanced wound care market are Smith & Nephew (U.K.), Johnson and Johnson (U.S), Medtronic (Ireland), 3M healthcare (U.S), Acelity, Ltd. (U.S.), Coloplast (Denmark), C.R.Bard (U.S.), Baxter International (U.S.),Cardinal Health (U.S.), Integra life science (U.S.) and B. Braun Melsungen AG (Germany).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
- â?¢ North America
- â?¢ Europe
- â?¢ Asia-Pacific
- â?¢ Rest of the World (RoW)